Medical Journals

Activation of 5-ht1a Receptors in Rostral Medullary Raphé Inhibits Cutaneous Vasoconstriction Elicited by Cold Exposure in Rabbits.

Authors:
  • Ootsuka Youichirou
  • Blessing William W

From: Department of Human Physiology, Centre for Neuroscience, Flinders University, Bedford Park, South Australia 5042, Australia. yoichiro.otsuka@flinders.edu.au

Brain research

  • Publish Date: Feb 2006
  • ISSN: 0006-8993
  • Volume: 1073-1074
  • Issue:
  • Pages: 252-61
  • Medium: Print
  • Language: English
  • Citation (JAMA): Ootsuka Youichirou, Blessing William W, et al. Activation of 5-ht1a Receptors in Rostral Medullary Raphé Inhibits Cutaneous Vasoconstriction Elicited by Cold Exposure in Rabbits.. Brain Res. Feb 2006;1073-1074:252-61

Abstract

In both conscious and anesthetized rabbits, we determined whether microinjection of a 5-hydroxytryptamine (5-HT) 1A receptor agonist 8-hydroxy-2-(di-n-propylaminio) tetralin (8-OH-DPAT) into the medullary raphé/parapyramidal region inhibits thermoregulatory vasoconstriction and whether microinjection of a 5-HT1A receptor antagonist (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl)-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride) (WAY-100635) into the raphé reverses the cutaneous vasomotor changes induced by intravenous administration of 8-OH-DPAT. In conscious rabbits with measuring ear pinna blood flow, after microinjection of 8-OH-DPAT (3-5 nmol in 300-500 nl) into the raphé, transferring the animal from a warm cage (25-28 degrees C) to a cold cage (5-10 degrees C) did not reduce the ear pinna flow (from 57 +/- 7 cm/s to 59 +/- 3 cm/s, P > 0.05, n = 5), unlike Ringer-treated animals. Microinjection of WAY-100635 (5 nmol in 500 nl) into the raphé reversed ear pinna flow changes induced by intravenous administration of 8-OH-DPAT (0.1 mg/kg, i.v.). In anesthetized rabbits with measuring postganglionic ear pinna sympathetic nerve activity, microinjection of 8-OH-DPAT (1-2 nmol in 100-200 nl) into the raphé reduced resting ear pinna sympathetic nerve activity to 14 +/- 4% of pre-injection level (P < 0.01, n = 12) and attenuated increases in ear pinna sympathetic nerve activity normally elicited by cooling the animal’s trunk. WAY-100635 (2 nmol into 200 nl) into the raphé reversed inhibition of ear pinna sympathetic nerve activity elicited by 8-OH-DPAT (0.1 mg/kg, i.v.). The activation of 5-HT1A receptors expressed on the medullary raphé neurons results in reversal of cold-elicited cutaneous vasoconstriction possibly through inhibition of sympathetic premotor neurons that innervate sympathetic preganglionic neurons controlling cutaneous vasomotion.

Mesh Headings (Keywords): 8-Hydroxy-2-(di-n-propylamino)tetralin, Analysis of Variance, Animals, Behavior, Animal, Blood Pressure, Body Temperature, Cold, Male, Piperazines, Pyridines, Rabbits, Raphe Nuclei, Receptor, Serotonin, 5-HT1A, Serotonin Agonists, Serotonin Antagonists, Skin, Sympathetic Nervous System, Ultrasonography, Doppler, Color, Vasoconstriction, Wakefulness


Check for Full Text / PubMed Unique Identifier (PMID): 16455061


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.